Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15565954rdf:typepubmed:Citationlld:pubmed
pubmed-article:15565954lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C1963724lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0920508lld:lifeskim
pubmed-article:15565954lifeskim:mentionsumls-concept:C0442821lld:lifeskim
pubmed-article:15565954pubmed:issue2-3lld:pubmed
pubmed-article:15565954pubmed:dateCreated2004-11-29lld:pubmed
pubmed-article:15565954pubmed:abstractTextWe report a 7-year HIV-1 clade A/E-infected child untreated with antiretroviral therapy who had positive HIV antibody testing but undetectable plasma HIV-1 RNA by Roche Amplicor version 1.5 and bDNA version 3.0. DNA PCR was positive by methods using gag/pol primers but not env/pol primers. The patient had strong HIV-1-specific cytotoxic T lymphocyte responses, which likely contributed to her low viral burden and undetectable plasma HIV-1 RNA.lld:pubmed
pubmed-article:15565954pubmed:languageenglld:pubmed
pubmed-article:15565954pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:citationSubsetIMlld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15565954pubmed:statusMEDLINElld:pubmed
pubmed-article:15565954pubmed:issn0125-877Xlld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:PancharoenChi...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:UbolyamSasiwi...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:RuxrungthamKi...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:AnanworanichJ...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:ApateerapongW...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:Sirivichayaku...lld:pubmed
pubmed-article:15565954pubmed:authorpubmed-author:Buranapraditk...lld:pubmed
pubmed-article:15565954pubmed:issnTypePrintlld:pubmed
pubmed-article:15565954pubmed:volume22lld:pubmed
pubmed-article:15565954pubmed:ownerNLMlld:pubmed
pubmed-article:15565954pubmed:authorsCompleteYlld:pubmed
pubmed-article:15565954pubmed:pagination165-9lld:pubmed
pubmed-article:15565954pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:meshHeadingpubmed-meshheading:15565954...lld:pubmed
pubmed-article:15565954pubmed:articleTitleUndetectable plasma HIV-1 RNA with strong gag-pol specific interferon-gamma ELISPOT response in an HIV-1 clade A/E-infected child untreated with antiretroviral therapy.lld:pubmed
pubmed-article:15565954pubmed:affiliationThe HIV Netherlands Australia Thailand Research Collaboration and the Thai Red Cross AIDS Research Center, Thailand.lld:pubmed
pubmed-article:15565954pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15565954pubmed:publicationTypeCase Reportslld:pubmed